Recently, it was confirmed that GPX4 inactivating agent not only inhibits triple negative breast cancer (TNBC) via promoting ferroptosis, but also reshapes the tumor microenvironment, thus turning the “cold” tumor of LAR-type TNBC into a “hot” tumor [13]. Here, GPX4 is linked to neoplasm.